Corvus

CRVS

CRVS Corvus NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CRVS Chart
    See on advanced chart >

    About

    Corvus Pharmaceuticals, Inc.was incorporated in Delaware on January 27, 2014 and began operations in November 2014.The company is a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies...
    • Highlight
      A clinical-stage biopharmaceutical company that developing immuno-oncology therapies to enhance the immune systems of patients with solid tumors and cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      03/23/2016
    • Established Date
      01/27/2014
    • Full-time Employees
      28
    • Address
      863 Mitten Road Suite 102 Burlingame CA 94010
    • Tel
      1-650-9004520
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock